Clenbuterol Antikörper

Produktnummer ABIN965905

Dieses Monoklonal-Antikörper erkennt spezifisch in ELISA. Er zeigt eine Reaktivität gegenüber und wurde in 2+ Publikationen erwähnt.

Kurzübersicht für Clenbuterol Antikörper (ABIN965905)

Target: Clenbuterol

Wirt: Bitte anfragen

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: ELISA

Produktdetails

Spezifität: Clenbuterol- KLH.

Aufreinigung: Antibodies are purified by protein G affinity chromatography.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA: Propose dilution 1: 10,000.
Determining optimal working dilutions by titration test.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: -20 °C

Referenzen

Aharoni, Dantes, Oren, Amsterdam: "cAMP-mediated signals as determinants for apoptosis in primary granulosa cells." in: Experimental cell research, Vol. 218, Issue 1, pp. 271-82, (1995) (PubMed).

Hoshi, Furutani-Seiki, Seto, Tada, Asano: "Prevention of TCR-mediated apoptosis by the elevation of cAMP." in: International immunology, Vol. 6, Issue 7, pp. 1081-9, (1994) (PubMed).

Antigendetails

Target: Clenbuterol

Substanzklasse: Chemical

Hintergrund: Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. When employed as a fattening adjuvant, as compared with the therapeutic use, clenbuterol is administered in a 5 to 10 times higher dose. Therefore, it is possible that clenbuterol residues may lead to a risk for consumers after illegal administration. Using the clenbuterol monocalantibody, it is possible to detect clenbuterol and other agonists in urine, muscle and liver both rapidly and with accuracy.